Organos' cardiac microphysiological systems (MPS) and data science ecosystem can be used to illuminate effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia.
Partnerships to repurpose candidates lost through attrition.
Drug Discovery and Development
Cardiac disease model development, target identification, biomarker discovery and efficacy testing.
Contract Cardiac Safety Analysis
Mechanistic analysis of compound effect on electrophysiolgy and prediction of arrhythmia. Long-term studies to mimic clincial protocols.